William Lance Collection of M-series Drug Records 1964-1971

Creator
Lance, William R.
Size
3 linear feet (2 legal boxes, 2 archival boxes, 2 film boxes.)
Location

For current information on the location of these materials, please consult the Special Collections Research Center Reference Staff.

Call number
MC 00474

The William Lance Collection of M-series Drug Records contains reports, correspondence with the Federal Drug Administration, agreements, New Animal Drug Applications, and films relating to the development and testing of the M-99 drug and its antidotes, M50-50 and M-285. Records range in date from 1964 to 1971.

The M-series were revolutionary drugs in zoological health. The drugs are an analgesic which can cause catatonia at very low doseages; they are used for immobilising game animals. The M-series of drugs is composed of M-99, or etorphine, as well as M-99's antidotes, M50-50 and M-285. The drugs were developed in partnership between American Cyanamid Company of Pearl River, New York and Reckitt Sons, Ltd. of Hull, England. Reckitt Sons Ltd. conducted many laboratory tests of the drugs which helped to inform American Cyanamid Company's application to the New Animal Drug department of the FDA. Lederle Laboratories located in Pearl River, New York manufactured the drugs for export. William Lance's company, Wildlife Pharmaceuticals, acquired the records and the rights to the M-series drugs after its formation in 1981.

Biographical/historical note

The M-series were revolutionary drugs in zoological health. The drugs are an analgesic which can cause catatonia at very low doseages; they are used for immobilising game animals. The M-series of drugs is composed of M-99, or etorphine, as well as M-99's antidotes, M50-50 and M-285. The drugs were developed in partnership between American Cyanamid Company of Pearl River, New York and Reckitt Sons, Ltd. of Hull, England. Reckitt Sons Ltd. conducted many laboratory tests of the drugs which helped to inform American Cyanamid Company's application to the New Animal Drug department of the FDA. Lederle Laboratories located in Pearl River, New York manufactured the drugs for export. William Lance's company, Wildlife Pharmaceuticals, acquired the records and the rights to the M-series drugs after its formation in 1981.

Scope/content

The William Lance Collection of M-series Drug Records contains reports, correspondence with the Federal Drug Administration, agreements, New Animal Drug Applications, and films relating to the development and testing of the M-99 drug and its antidotes, M50-50 and M-285. Records range in date from 1964 to 1971.

Arrangement

The collection is organized by material type and arranged chronologically.

Use of these materials

The nature of the NCSU Libraries' Special Collections means that copyright or other information about restrictions may be difficult or even impossible to determine despite reasonable efforts. The NCSU Libraries claims only physical ownership of most Special Collections materials.

The materials from our collections are made available for use in research, teaching, and private study, pursuant to U.S. Copyright law. The user must assume full responsibility for any use of the materials, including but not limited to, infringement of copyright and publication rights of reproduced materials. Any materials used for academic research or otherwise should be fully credited with the source.

Preferred Citation

[Identification of item], William Lance Collection of M-series Drug Records, MC 00474, Special Collections Research Center, North Carolina State University Libraries, Raleigh, NC

Source of acquisition

Gift of William R. Lance, 2013 (Accession 2013.0047).

Toxicological and Pharmacological Studies of M.285 - a Derivative of Tetrahydro-oripavine 1964
Legal box 1, Folder 1
M-series (Reckitt) Scientific Memorandum, Prepared on the Occasion of the Licensing Agreement between American Cyanamid Company, Pearl River, NY, USA and Reckitt Sons, Ltd., Hull, England 1964
Legal box 1, Folder 2
Report on Visit to Reckitt Sons Limited, 20th-23rd September 1965 1965
Legal box 1, Folder 3
Cyanamid/Reckitt Agreement, Six Monthly Report, January-June 1966 1966
Legal box 1, Folder 4
Cyanamid/Reckitt Agreement, Visit by Representatives of Cyanamid to Reckitt Sons Ltd., Hull, England, 12th-14th October 1966 1966
Legal box 1, Folder 5
M99 (Reckitt) a Highly Potent Morphine-like Analgesic Drug 1966
Legal box 2, Folder 1
Reckitt-Lederle Research Report 1967
Legal box 2, Folder 2
Reckitt-Lederle Agreement, Six Monthly Meeting, Sept 30th-Oct 1st 1968 1968
Legal box 2, Folder 3
Reckitt-Lederle Research Report, July-November 1968 1968
Legal box 2, Folder 4
Report of Visit of Representatives of Reckitt and Sons, Ltd. to Lederle Laboratories, Pearl River, New York, February 21, 1969 1969
Legal box 2, Folder 5
M-99 Etophine (VIND 87) M-285 Cyprenorphine, FDA Corr. Vol. 1 1966-1969
Box 3, Folder 1
M99, M50-50, and M285 For Use in Exotic Animals, Volume I, NADA 47-870, Submitted June 18, 1971 1971
Box 4, Folder 1
M99, M50-50, and M285 For Use in Exotic Animals, Volume XI, NADA, Submitted June 18, 1971 1971
Box 4, Folder 2
M99 Horses 196?

16mm film; Approximate runtime: 10 minutes; color; no sound

Reel box 5
New Analgesia Tranquilizer Mixture First Version

16mm film; Approximate runtime: 12 minutes; color, sound

Reel box 6

Access to the collection

This collection is open for research; access requires at least 48 hours advance notice.

For more information contact us via mail, phone, or our web form.

Mailing address:
Special Collections Research Center
Box 7111
Raleigh, NC, 27695-7111

Phone: (919) 515-2273

Preferred Citation

[Identification of item], William Lance Collection of M-series Drug Records, MC 00474, Special Collections Research Center, North Carolina State University Libraries, Raleigh, NC

Use of these materials

The nature of the NCSU Libraries' Special Collections means that copyright or other information about restrictions may be difficult or even impossible to determine despite reasonable efforts. The NCSU Libraries claims only physical ownership of most Special Collections materials.

The materials from our collections are made available for use in research, teaching, and private study, pursuant to U.S. Copyright law. The user must assume full responsibility for any use of the materials, including but not limited to, infringement of copyright and publication rights of reproduced materials. Any materials used for academic research or otherwise should be fully credited with the source.